GenePlanet secures strategic investment from Lauxera Capital Partners to fuel growth. This funding will support GenePlanet's expansion in the health tech space.
BlackPeak CapitalBlack Peak CapitalLauxera Capital Partners
Description
GenePlanet, a Ljubljana-based genomics platform, has secured a strategic investment from Lauxera Capital Partners. This investment allows existing investor BlackPeak Capital to partially exit while retaining a meaningful shareholding. GenePlanet aims to accelerate its growth with Lauxera's market expertise. The company has been successful in launching proprietary products and expanding into over 50 markets.
Company Information
Company
GenePlanet
Location
Slovenia
About
GenePlanet is a Ljubljana-based genomics and laboratory platform that delivers advanced genetic testing and next-generation sequencing (NGS) services worldwide. Founded in 2008, it offers a comprehensive portfolio of clinical, research, and preventive genomic solutions, alongside fully integrated NGS services for healthcare and research partners globally. Over the years, GenePlanet has expanded its footprint to more than 50 markets and completed four acquisitions, solidifying its standing as a leading genetic-testing laboratory platform in the region.
Fundz sees it the moment GenePlanet raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.